Cresset Asset Management, LLC Morpho Sys Ag Transaction History

Cresset Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.87 - $9.73 $208,420 - $345,473	-35,506 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$9.08 - $12.45 $128,291 - $175,906	14,129 Added 66.09%	35,506 $334,000
Q3 2021 Nov 15, 2021	BUY	$11.76 - $19.51 $110,790 - $183,803	9,421 Added 78.8%	21,377 $252,000
Q2 2021 Aug 10, 2021	BUY	$18.95 - $23.95 $226,566 - $286,346	11,956 New	11,956 $230,000

11.3M

320K

1.1M

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Market Cap $2.47B
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.